Advancing Alzheimer’s disease risk prediction: development and validation of a machine learning-based preclinical screening model in a cross-sectional study
Objectives Alzheimer’s disease (AD) poses a significant challenge for individuals aged 65 and older, being the most prevalent form of dementia. Although existing AD risk prediction tools demonstrate high accuracy, their complexity and limited accessibility restrict practical application. This study...
Saved in:
Main Authors: | Yanfei Chen, Bing Wang, Yankai Shi, Wenhao Qi, Shihua Cao, Bingsheng Wang, Ruihan Xie, Jiani Yao, Xiajing Lou, Chaoqun Dong, Xiaohong Zhu, Danni He |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-02-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/15/2/e092293.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioinformatics screening and clinical validation of CircRNA and related miRNA in male osteoporosis
by: Jiayi Li, et al.
Published: (2025-02-01) -
The Dorsiflexion Range of Motion Screen: A Validation Study
by: Phillip J Plisky, et al.
Published: (2021-04-01) -
A comprehensive review of Schisandrin B’s preclinical antitumor activity and mechanistic insights from network pharmacology
by: Yanhua Fang, et al.
Published: (2025-02-01) -
β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
by: Bing Xu, et al.
Published: (2025-02-01) -
Advances in preclinical and clinical studies of oncolytic virus combination therapy
by: Wenlong Du, et al.
Published: (2025-02-01)